Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018.

Haddad RI, Nasr C, Bischoff L, Busaidy NL, Byrd D, Callender G, Dickson P, Duh QY, Ehya H, Goldner W, Haymart M, Hoh C, Hunt JP, Iagaru A, Kandeel F, Kopp P, Lamonica DM, McIver B, Raeburn CD, Ridge JA, Ringel MD, Scheri RP, Shah JP, Sippel R, Smallridge RC, Sturgeon C, Wang TN, Wirth LJ, Wong RJ, Johnson-Chilla A, Hoffmann KG, Gurski LA.

J Natl Compr Canc Netw. 2018 Dec;16(12):1429-1440. doi: 10.6004/jnccn.2018.0089.

PMID:
30545990
2.

Lymph node ratio predicts recurrence in pediatric papillary thyroid cancer.

Rubinstein JC, Dinauer C, Herrick-Reynolds K, Morotti R, Callender GG, Christison-Lagay ER.

J Pediatr Surg. 2019 Jan;54(1):129-132. doi: 10.1016/j.jpedsurg.2018.10.010. Epub 2018 Oct 5.

PMID:
30361076
3.

The Value of Negative Diagnosis in Thyroid Fine-Needle Aspiration: a Retrospective Study with Histologic Follow-Up.

Abi-Raad R, Prasad M, Baldassari R, Schofield K, Callender GG, Chhieng D, Adeniran AJ.

Endocr Pathol. 2018 Sep;29(3):269-275. doi: 10.1007/s12022-018-9536-5.

PMID:
29949024
4.

DNA Mismatch Repair Deficiency Promotes Genomic Instability in a Subset of Papillary Thyroid Cancers.

Javid M, Sasanakietkul T, Nicolson NG, Gibson CE, Callender GG, Korah R, Carling T.

World J Surg. 2018 Feb;42(2):358-366. doi: 10.1007/s00268-017-4299-6.

PMID:
29075860
5.

Identification of distinct cytomorphologic features in the diagnosis of NIFTP at the time of preoperative FNA: Implications for patient management.

Chandler JB, Colunga M, Prasad ML, Callender GG, Quinn C, Chhieng D, Adeniran AJ.

Cancer Cytopathol. 2017 Nov;125(11):865-875. doi: 10.1002/cncy.21910. Epub 2017 Aug 21.

6.

Parathyroidectomy prior to kidney transplant decreases graft failure.

Callender GG, Malinowski J, Javid M, Zhang Y, Huang H, Quinn CE, Carling T, Tomlin R, Smith JD, Kulkarni S.

Surgery. 2017 Jan;161(1):44-50. doi: 10.1016/j.surg.2016.10.003. Epub 2016 Nov 15.

PMID:
27863776
7.

Primary hyperparathyroidism with normal baseline intraoperative parathyroid hormone: A challenging population.

Javid M, Callender G, Quinn C, Carling T, Donovan P, Udelsman R.

Surgery. 2017 Feb;161(2):493-498. doi: 10.1016/j.surg.2016.08.018. Epub 2016 Oct 4.

PMID:
27712879
8.

Leptin Is Produced by Parathyroid Glands and Stimulates Parathyroid Hormone Secretion.

Hoang D, Broer N, Sosa JA, Abitbol N, Yao X, Li F, Rivera-Molina F, Toomre DK, Roman SA, Sue G, Kim S, Li AY, Callender GG, Simpson C, Narayan D.

Ann Surg. 2017 Dec;266(6):1075-1083. doi: 10.1097/SLA.0000000000002004.

PMID:
27611607
9.

Shifting patterns of genomic variation in the somatic evolution of papillary thyroid carcinoma.

Rubinstein JC, Brown TC, Christison-Lagay ER, Zhang Y, Kunstman JW, Juhlin CC, Nelson-Williams C, Goh G, Quinn CE, Callender GG, Udelsman R, Lifton RP, Korah R, Carling T.

BMC Cancer. 2016 Aug 18;16:646. doi: 10.1186/s12885-016-2665-7.

10.

Dissection of Levels II Through V Is Required for Optimal Outcomes in Patients with Lateral Neck Lymph Node Metastasis from Papillary Thyroid Carcinoma.

Javid M, Graham E, Malinowski J, Quinn CE, Carling T, Udelsman R, Callender GG.

J Am Coll Surg. 2016 Jun;222(6):1066-73. doi: 10.1016/j.jamcollsurg.2016.02.006. Epub 2016 Feb 19.

PMID:
27049777
11.

Hepatitis C virus-cross-reactive TCR gene-modified T cells: a model for immunotherapy against diseases with genomic instability.

Spear TT, Riley TP, Lyons GE, Callender GG, Roszkowski JJ, Wang Y, Simms PE, Scurti GM, Foley KC, Murray DC, Hellman LM, McMahan RH, Iwashima M, Garrett-Mayer E, Rosen HR, Baker BM, Nishimura MI.

J Leukoc Biol. 2016 Sep;100(3):545-57. doi: 10.1189/jlb.2A1215-561R. Epub 2016 Feb 26.

12.

TCR gene-modified T cells can efficiently treat established hepatitis C-associated hepatocellular carcinoma tumors.

Spear TT, Callender GG, Roszkowski JJ, Moxley KM, Simms PE, Foley KC, Murray DC, Scurti GM, Li M, Thomas JT, Langerman A, Garrett-Mayer E, Zhang Y, Nishimura MI.

Cancer Immunol Immunother. 2016 Mar;65(3):293-304. doi: 10.1007/s00262-016-1800-2. Epub 2016 Feb 3.

13.

Something old, something new: Marrying 2 approaches to resect an ectopic parathyroid adenoma.

Dinga Madou I, Callender GG, Kim AW.

J Thorac Cardiovasc Surg. 2016 Feb;151(2):e33-4. doi: 10.1016/j.jtcvs.2015.09.105. No abstract available.

14.

Anaplastic Thyroid Carcinoma, Version 2.2015.

Haddad RI, Lydiatt WM, Ball DW, Busaidy NL, Byrd D, Callender G, Dickson P, Duh QY, Ehya H, Haymart M, Hoh C, Hunt JP, Iagaru A, Kandeel F, Kopp P, Lamonica DM, McCaffrey JC, Moley JF, Parks L, Raeburn CD, Ridge JA, Ringel MD, Scheri RP, Shah JP, Smallridge RC, Sturgeon C, Wang TN, Wirth LJ, Hoffmann KG, Hughes M.

J Natl Compr Canc Netw. 2015 Sep;13(9):1140-50.

15.

Operative failure rate and documentation of family history in young patients undergoing focused parathyroidectomy for primary hyperparathyroidism.

Stephen ET, Quillo AR, Lewis KE, Harden FL, Bumpous JM, Flynn MB, Callender GG.

Am Surg. 2015 Jun;81(6):585-90.

PMID:
26031271
16.

Real-Time Super Selective Venous Sampling in Remedial Parathyroid Surgery.

Lebastchi AH, Aruny JE, Donovan PI, Quinn CE, Callender GG, Carling T, Udelsman R.

J Am Coll Surg. 2015 Jun;220(6):994-1000. doi: 10.1016/j.jamcollsurg.2015.01.004. Epub 2015 Jan 22.

PMID:
25868412
17.

Maintenance of certification: what everyone needs to know.

Callender GG, Kaplan BJ, White RL, Brenin DR, Chagpar AB, Dalal KM, Howard-McNatt M, Howe J, Kim J, Kurtzman SH, Mansour JC, Mittendorf EA, Stewart JH 4th, Temple LK, Stella P, Cummings C, Wong SL, Klimberg VS.

Ann Surg Oncol. 2015 Apr;22(4):1051-4. doi: 10.1245/s10434-014-4306-1. Epub 2015 Feb 7. No abstract available.

PMID:
25663592
18.

Modern experience with aggressive parathyroid tumors in a high-volume New England referral center.

Quinn CE, Healy J, Lebastchi AH, Brown TC, Stein JE, Prasad ML, Callender GG, Carling T, Udelsman R.

J Am Coll Surg. 2015 Jun;220(6):1054-62. doi: 10.1016/j.jamcollsurg.2014.10.007. Epub 2014 Oct 24.

PMID:
25488353
19.

Surgery for primary hyperparathyroidism.

Callender GG, Udelsman R.

Cancer. 2014 Dec 1;120(23):3602-16. doi: 10.1002/cncr.28891. Epub 2014 Jul 9. Review.

20.

Thyroid cancer.

Lebastchi AH, Callender GG.

Curr Probl Cancer. 2014 Mar-Apr;38(2):48-74. doi: 10.1016/j.currproblcancer.2014.04.001. Epub 2014 May 14. Review. No abstract available.

PMID:
24951026
21.

Surgery for thyroid cancer.

Callender GG, Carling T, Christison-Lagay E, Udelsman R.

Endocrinol Metab Clin North Am. 2014 Jun;43(2):443-58. doi: 10.1016/j.ecl.2014.02.011. Review.

PMID:
24891171
22.

Prognostic factors in young women with cutaneous melanoma.

Burton AL, Egger ME, Quillo AR, Stromberg AJ, Hagendoorn L, Scoggins CR, Martin RC 2nd, McMasters KM, Callender GG.

Am J Surg. 2014 Jan;207(1):102-8. doi: 10.1016/j.amjsurg.2013.10.002. Epub 2013 Oct 25.

PMID:
24330977
23.

Outcomes and prognostic factors in superficial spreading melanoma.

Egger ME, Stepp LO, Callender GG, Quillo AR, Martin RC 2nd, Scoggins CR, Stromberg AJ, McMasters KM.

Am J Surg. 2013 Dec;206(6):861-7; discussion 867-8. doi: 10.1016/j.amjsurg.2013.09.003. Epub 2013 Oct 1.

PMID:
24124662
24.

Clinical evaluation of somatostatin use in pancreatic resections: Clinical efficacy or limited benefit?

Anderson RJ, Dunki-Jacobs E, Callender GG, Burnett N, Scoggins CR, McMasters KM, Martin RC 2nd.

Surgery. 2013 Oct;154(4):755-60; discussion 760. doi: 10.1016/j.surg.2013.07.001.

PMID:
24074412
25.

Current management of melanoma.

Dunki-Jacobs EM, Callender GG, McMasters KM.

Curr Probl Surg. 2013 Aug;50(8):351-82. doi: 10.1067/j.cpsurg.2013.04.001. Review. No abstract available.

PMID:
23849560
26.

Evaluation of alpha-fetoprotein staging system for hepatocellular carcinoma in noncirrhotic patients.

Burnett NP, Dunki-Jacobs EM, Callender GG, Anderson RJ, Scoggins CR, McMasters KM, Martin RC.

Am Surg. 2013 Jul;79(7):716-22.

PMID:
23816006
27.

Incidence of sentinel lymph node involvement in a modern, large series of desmoplastic melanoma.

Egger ME, Huber KM, Dunki-Jacobs EM, Quillo AR, Scoggins CR, Martin RC 2nd, Stromberg AJ, McMasters KM, Callender GG.

J Am Coll Surg. 2013 Jul;217(1):37-44; discussion 44-5. doi: 10.1016/j.jamcollsurg.2013.05.006.

PMID:
23791271
28.

Financial comparison of laparoscopic versus open hepatic resection using deviation-based cost modeling.

Cannon RM, Scoggins CR, Callender GG, Quillo A, McMasters KM, Martin RC 2nd.

Ann Surg Oncol. 2013 Sep;20(9):2887-92. doi: 10.1245/s10434-013-2993-7. Epub 2013 May 1.

PMID:
23636514
29.

Assessment of chemotherapy response in colorectal liver metastases in patients undergoing hepatic resection and the correlation to pathologic residual viable tumor.

Egger ME, Cannon RM, Metzger TL, Nowacki M, Kelly L, Tatum C, Scoggins CR, Callender GG, McMasters KM, Martin RC 2nd.

J Am Coll Surg. 2013 Apr;216(4):845-56; discussion 856-7. doi: 10.1016/j.jamcollsurg.2012.12.037. Epub 2013 Feb 13.

PMID:
23415549
30.

A phase 2 trial of once-weekly hypofractionated breast irradiation: first report of acute toxicity, feasibility, and patient satisfaction.

Dragun AE, Quillo AR, Riley EC, Roberts TL, Hunter AM, Rai SN, Callender GG, Jain D, McMasters KM, Spanos WJ.

Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):e123-8. doi: 10.1016/j.ijrobp.2012.10.021. Epub 2012 Nov 27.

PMID:
23195779
31.

Diversity of stage III melanoma in the era of sentinel lymph node biopsy.

Egger ME, Callender GG, McMasters KM, Ross MI, Martin RC 2nd, Edwards MJ, Urist MM, Noyes RD, Sussman JJ, Reintgen DS, Stromberg AJ, Scoggins CR.

Ann Surg Oncol. 2013 Mar;20(3):956-63. doi: 10.1245/s10434-012-2701-z. Epub 2012 Oct 14.

PMID:
23064795
32.

Assessment of mitotic rate reporting in melanoma.

Burton AL, Egger ME, Gilbert JE, Stromberg AJ, Hagendoorn L, Martin RC, Scoggins CR, McMasters KM, Callender GG.

Am J Surg. 2012 Dec;204(6):969-74; discussion 974-5. doi: 10.1016/j.amjsurg.2012.05.021. Epub 2012 Oct 1.

PMID:
23036603
33.

Unique prognostic factors in acral lentiginous melanoma.

Egger ME, McMasters KM, Callender GG, Quillo AR, Martin RC 2nd, Stromberg AJ, Scoggins CR.

Am J Surg. 2012 Dec;204(6):874-9; discussion 879-80. doi: 10.1016/j.amjsurg.2012.05.013. Epub 2012 Sep 28.

PMID:
23022254
34.

The lymph node ratio has limited prognostic significance in melanoma.

Egger ME, Scoggins CR, Martin RC 2nd, Stromberg AJ, Quillo AR, McMasters KM, Callender GG.

J Surg Res. 2013 Jan;179(1):10-7. doi: 10.1016/j.jss.2012.08.050. Epub 2012 Sep 5.

PMID:
22967706
35.

Laparoscopic versus open resection of hepatic colorectal metastases.

Cannon RM, Scoggins CR, Callender GG, McMasters KM, Martin RC 2nd.

Surgery. 2012 Oct;152(4):567-73; discussion 573-4. doi: 10.1016/j.surg.2012.07.013. Epub 2012 Sep 1.

PMID:
22943842
36.

Outcomes and prognostic factors in nodular melanomas.

Egger ME, Dunki-Jacobs EM, Callender GG, Quillo AR, Scoggins CR, Martin RC 2nd, Stromberg AJ, McMasters KM.

Surgery. 2012 Oct;152(4):652-9; discussion 659-60. doi: 10.1016/j.surg.2012.07.006. Epub 2012 Aug 25.

PMID:
22925134
37.

Clinicopathologic and survival differences between upper and lower extremity melanomas.

Egger ME, Tabler BL, Dunki-Jacobs EM, Callender GG, Scoggins CR, Martin RC 2nd, Quillo AR, Stromberg AJ, McMasters KM.

Am Surg. 2012 Jul;78(7):779-87.

PMID:
22748538
38.

Multi-institutional analysis of pancreatic adenocarcinoma demonstrating the effect of diabetes status on survival after resection.

Cannon RM, LeGrand R, Chagpar RB, Ahmad SA, McClaine R, Kim HJ, Rupp C, Cho CS, Brinkman A, Weber S, Winslow ER, Kooby DA, Chu CK, Staley CA, Glenn I, Hawkins WG, Parikh AA, Merchant NB, McMasters KM, Martin RC, Callender GG, Scoggins CR.

HPB (Oxford). 2012 Apr;14(4):228-35. doi: 10.1111/j.1477-2574.2011.00432.x. Epub 2012 Jan 19.

39.

A novel and accurate computer model of melanoma prognosis for patients staged by sentinel lymph node biopsy: comparison with the American Joint Committee on Cancer model.

Callender GG, Gershenwald JE, Egger ME, Scoggins CR, Martin RC 2nd, Schacherer CW, Edwards MJ, Urist MM, Ross MI, Stromberg AJ, McMasters KM.

J Am Coll Surg. 2012 Apr;214(4):608-17; discussion 617-9. doi: 10.1016/j.jamcollsurg.2011.12.027. Epub 2012 Feb 17.

PMID:
22342785
40.

Preoperative serum osteocalcin may predict postoperative elevated parathyroid hormone in patients with primary hyperparathyroidism.

Rianon N, Alex G, Callender G, Jimenez C, Hu M, Grubbs E, Moreno M, Wathoo C, Petak S, Perrier N.

World J Surg. 2012 Jun;36(6):1320-6. doi: 10.1007/s00268-012-1432-4.

PMID:
22278606
41.

Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thicker.

Callender GG, Egger ME, Burton AL, Scoggins CR, Ross MI, Stromberg AJ, Hagendoorn L, Martin RC 2nd, McMasters KM.

Am J Surg. 2011 Dec;202(6):659-64; discussion 664-5. doi: 10.1016/j.amjsurg.2011.06.048.

PMID:
22137134
42.

Readmission rates after abdominal surgery: the role of surgeon, primary caregiver, home health, and subacute rehab.

Martin RC, Brown R, Puffer L, Block S, Callender G, Quillo A, Scoggins CR, McMasters KM.

Ann Surg. 2011 Oct;254(4):591-7.

PMID:
22039606
43.

What does ulceration of a melanoma mean for prognosis?

Callender GG, McMasters KM.

Adv Surg. 2011;45:225-36. Review.

PMID:
21954690
44.

Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.

Burton AL, Gilbert J, Farmer RW, Stromberg AJ, Hagendoorn L, Ross MI, Martin RC 2nd, McMasters KM, Scoggins CR, Callender GG.

Am Surg. 2011 Aug;77(8):1009-13.

PMID:
21944515
45.

Lymphovascular invasion as a prognostic factor in melanoma.

Egger ME, Gilbert JE, Burton AL, McMasters KM, Callender GG, Quillo AR, Brown RE, St Hill CR, Hagendoorn L, Martin RC 2nd, Stromberg AJ, Scoggins CR.

Am Surg. 2011 Aug;77(8):992-7.

PMID:
21944512
46.

Safety and efficacy of hepatectomy for colorectal metastases in the elderly.

Cannon RM, Martin RC, Callender GG, McMasters KM, Scoggins CR.

J Surg Oncol. 2011 Dec;104(7):804-8. doi: 10.1002/jso.22042. Epub 2011 Jul 25.

PMID:
21792943
47.

recurrence following hepatectomy for metastatic colorectal cancer: development of a model that predicts patterns of recurrence and survival.

Hill CR, Chagpar RB, Callender GG, Brown RE, Gilbert JE, Martin RC 2nd, McMasters KM, Scoggins CR.

Ann Surg Oncol. 2012 Jan;19(1):139-44. doi: 10.1245/s10434-011-1921-y. Epub 2011 Jul 13.

PMID:
21751045
48.

Early versus delayed complete lymphadenectomy in melanoma: insight from MSLT I.

Callender GG, McMasters KM.

Ann Surg Oncol. 2011 Feb;18(2):306-8. doi: 10.1245/s10434-010-1481-6. No abstract available.

PMID:
21161723
49.

Common locations of parathyroid adenomas.

Moreno MA, Callender GG, Woodburn K, Edeiken-Monroe BS, Grubbs EG, Evans DB, Lee JE, Perrier ND.

Ann Surg Oncol. 2011 Apr;18(4):1047-51. doi: 10.1245/s10434-010-1429-x. Epub 2010 Nov 20.

PMID:
21104031
50.

Paraganglioma syndrome type 1 in a patient with Carney-Stratakis syndrome.

Ayala-Ramirez M, Callender GG, Kupferman ME, Rich TA, Chuang HH, Trent J, Perrier ND, Goodarzi M, Jimenez C.

Nat Rev Endocrinol. 2010 Feb;6(2):110-5. doi: 10.1038/nrendo.2009.250.

PMID:
20098451

Supplemental Content

Loading ...
Support Center